Abstract
Introduction
The childhood leukaemia represents about 35% of all childhood malignancies and ALL is the commonest form of them 1 . In USA annually 2500-3500 children are diagnosed with ALL2. After diagnosis of ALL polychemotherapy may be given to the patient on different phases 3 . For early detection of responsivenessor unresponsiveness of chemotherapy monitoring of bone marrow recovery are needed 3 . Among the conventional haematoilogical parameters reticulocyte count with IRF has been establishehd as a reliable indicator in different studies 4 . Reticulocytes are immature red blood cells. They are released in the peripheral blood after a period of maturation in the bone marrow and undergo further differentiation into mature RBCs. In automated flowcytometry method, reticulocyts have been classified morphologically into three maturational stages:low (LFR), middle (MFR) and high fluroscent reticulocytes (HFR)6. Immature Reticulocyte Fraction (IRF) is defined as the ratio of young or immature reticulocytes to the total number of reticulocytes. They are larger, having the greatest light scatter properties due to the highest level of RNA. Immature reticulocytes normally constitute less than five percent (5%) of the total number of reticulocytes 7 . It is released into the peripheral blood during periods of intense erythropoietic stimulation, An increase in the reticulocyte percent > 1% or an increase in the absolute reticulocyte count~50 x 10 9 /L is used as an indicator of erythroid regeneration 2 ,8 . Spanish Multicentric Study Group for Haematopoietic recovery defined IRF > 5% and HFR > 3% as recovery8. Absolute neutrophil count (ANC) is defined as the number of mature neutrophils plus bands per unit of volume generally accepted as a primary indicator of successful bone marrow recovery. An increase in ANC~0.5 x10 9 /L defines successful myeloid recovery after chemotherapy4,9,10. The aim of this study is to find out sensitive indicator of marrow recovery among the reticulocyte subpopulations assesed by automated method in children with ALL.
Materials and Methods
This cross sectional study was carried out in the Department of Clinical Pathology and Department of Paediatric Haematology and Oncology, BSMMU, Dhaka during the period of October' 2009 to MSYesmin, A Nesa, T Sultana, CK Roy, MQRahman etal September' 2010. 50 Children upto 18 years of age irrespective of sex with acute lymphoblastic leukaemia attended in Paediatric Hemato-Oncology outpatients & inpatients department for treatment included in this study. Reticulocyte counting was carried out in the Sysmex xt-2000i automated haematology analyzer with reticulocyte counter. Blood sample (2 ml) was collected in an EDTA tube for complete blood count (CBC), ANC, reticulocyte profile (both manual and automated method) and PBF examination. Count was done preferably within 2 hrs of collection. If delayed, blood sample was kept at 4°C before test. ANC was calculated from total leucocyte count and differential count of WBC.
Supravital staining of unfixed RBCs was done with new methylene blue (NMB) in 50 patients and 40 controls. Then mixing of 100 1-11 whole blood with 100 1-11 of 1% NMB solution in a 10x75-mm tube. After incubation at 37°for 15-20 minutes, the dilution was remixed and a wedge smear was perlormed 11 . The number of reticulocytes per 1000 RBCs determined microscopically on x100 objective. Then percentage of reticulocyte was done. A reticulocyte was defined as a RBC containing at least 2 granules of reticulum(Figure-I}. Absolute reticulocyte count was calculated from RBC count obtained from automated haematology analyzer.
Automated reticulocyte count was done in 50 patients in Sysmex xt-2000i haematology analyzer. The measuring principle of the system is based on flow cytometry combined with hydrodynamic focusing. EDTA blood (100 I-II) is aspirated and intracellular RNA is stained by auramine 0, which is f1uroscentunder argon laser Iight 12 .The reticulocyte population is further subdivided into LFR, MFR and HFR (Figure-II 
Results
In present study randomly enrolled 50 patients were taken. Fiftey children were 8 months to 15 years of age range and mean age of the patients was 5.5 ±3.2 years. Maximum patients were male. Male and female ratio was 1.5:1. In this study during induction remission phase Hb level were gradually decreased upto 12 th day (p<0.05). However from 16 th qay onwards the Hb level remain the similar with baseline status which was not significant (p>0.05). At diagnosis mean total count of RBC was 4.0±0.9 (x1012/L). During induction remission total count of RBC was significantly declined upto 20 th day (p<0.05). At diagnosis mean total count of WBC was 14.74±25.47 (x10 9 /L). During induction remission total count of WBC was sharply declined at day 8 and continued up to last follow up. Statistically significant differences were observed between different follow-ups day (p<0.05}. The platelet c~unt was declined significantly (p<0.05) upto 16 days then remain the same with the baseline status. Recovery of platelet counts occurred at a median of 24 day, which was 1 day delayed, to recovery of ANC (Table-I ). In this study reticulocyte (ret) % significantly declined upto day 4 and then gradually increased or remain the same with the diagnosis day in both automated and manual method. Reticulocyte % recovery occurred first day of persistent 3-days rise of the reticulocyte (ret) from the 18th day to 28 days (20 days), which was 4 days later than IRF (Table-II) . The absolute reticulocyte concentration significantly declined upto day 4 then it remain the same upto last follow up. It recovered at a median of 18 days 2 days later than IRF (Table-II} . This study showed IRF declined gradually in 24 cases and reaches to low-level mean of 12.1±7.1 % with a median of 6 days (days 4-8). But IRF showed high range at diagnosis before the chemotherapy. Recovery day was ranged from 16.6±4.6 (median day 16)( Table-I} . This stUdy showed the HFR status declined significantly upto day 8 and then increased upto 28 th day. The HFR recovery occurred from 10 to 32 days with a median of 18 days(Table-II}, which was 2 days later than IRF but 5 days earlier than ANC. In this study the children were profoundly neutropenic «500/ml) in day 12 and day 16. The ANC were remain the same with the day of diagnosis from day 20 to 32 day of the therapy. The ANC were significantly (p<0.05) declined upto day 16 of therapy. The range of ANC recovery was 10-32 days (median 23 day) ( Table-I ). This stUdy concluded that the IRF parameter showed earlier haematopoietic recovery than the current practice of ANC recovery for monitoring in children with acute l¥mphoblastic leukemia after chemotherapy. This early laboratory indicator will guide the clinicians to make important therapeutic decisions, which will be economic savings and as well as live saving. Nowadays, IRF is offered most of the third generation haematology analyzer. Moreover, this test is simple, quick, cost effective, reproducible and reliable tool on the automated haematology analyzer. Thus its potential use as a routine test to see the bone marrow recovery is important.
